746 related articles for article (PubMed ID: 19639712)
1. National Authority for Health: France.
Rochaix L; Xerri B
Issue Brief (Commonw Fund); 2009 Jul; 58():1-9. PubMed ID: 19639712
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
Lopert R
Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
[TBL] [Abstract][Full Text] [Related]
3. Institute for Quality and Efficiency in Health Care: Germany.
Nasser M; Sawicki P
Issue Brief (Commonw Fund); 2009 Jul; 57():1-12. PubMed ID: 19639711
[TBL] [Abstract][Full Text] [Related]
4. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness review within the U.K.'s National Institute for Health and Clinical Excellence.
Chalkidou K
Issue Brief (Commonw Fund); 2009 Jul; 59():1-12. PubMed ID: 19639713
[TBL] [Abstract][Full Text] [Related]
6. Role of technology assessment in health benefits coverage for medical devices.
Braslow NM; Shatin D; McCarthy DB; Newcomer LN
Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
[TBL] [Abstract][Full Text] [Related]
7. NICE's use of cost effectiveness as an exemplar of a deliberative process.
Culyer AJ
Health Econ Policy Law; 2006 Jul; 1(Pt 3):299-318. PubMed ID: 18634698
[TBL] [Abstract][Full Text] [Related]
8. Harmonization of evidence requirements for health technology assessment in reimbursement decision making.
Hutton J; Trueman P; Facey K
Int J Technol Assess Health Care; 2008; 24(4):511-7. PubMed ID: 18828948
[TBL] [Abstract][Full Text] [Related]
9. Coverage with Evidence Development: applications and issues.
Trueman P; Grainger DL; Downs KE
Int J Technol Assess Health Care; 2010 Jan; 26(1):79-85. PubMed ID: 20059784
[TBL] [Abstract][Full Text] [Related]
10. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
Gibis B; Rheinberger P
Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
[TBL] [Abstract][Full Text] [Related]
11. Introduction of emerging medical devices on the market: a new procedure in Belgium.
Vinck I; Neyt M; Thiry N; Louagie M; Ramaekers D
Int J Technol Assess Health Care; 2007; 23(4):449-54. PubMed ID: 17937833
[TBL] [Abstract][Full Text] [Related]
12. Technology assessment, coverage decisions, and conflict: the role of guidelines.
Sheingold SH
Am J Manag Care; 1998 Sep; 4 Spec No():SP117-25. PubMed ID: 10185988
[TBL] [Abstract][Full Text] [Related]
13. Canada's National Advisory Committee on Immunization (NACI): evidence-based decision-making on vaccines and immunization.
Ismail SJ; Langley JM; Harris TM; Warshawsky BF; Desai S; FarhangMehr M
Vaccine; 2010 Apr; 28 Suppl 1():A58-63. PubMed ID: 20412999
[TBL] [Abstract][Full Text] [Related]
14. Decision making the explicit evidence-based way: comparing benefits, harms and costs.
McArthur J; Dickinson A
Nurs Prax N Z; 1999 Mar; 14(1):33-42. PubMed ID: 10481662
[TBL] [Abstract][Full Text] [Related]
15. The trouble with medical innovation.
Moskowitz DB
Bus Health; 1999 May; 17(5):38-42. PubMed ID: 10387675
[No Abstract] [Full Text] [Related]
16. Health technology assessment and policy decisions on hyperbaric oxygen treatment.
Mitton C; Hailey D
Int J Technol Assess Health Care; 1999; 15(4):661-70. PubMed ID: 10645107
[TBL] [Abstract][Full Text] [Related]
17. Assessment and regulation of health care technology. The Dutch experience.
Boer A
Int J Technol Assess Health Care; 1999; 15(4):638-48. PubMed ID: 10645105
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis and formulary decision making in England: findings from research.
Williams IP; Bryan S
Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
[TBL] [Abstract][Full Text] [Related]
19. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
